Age and kidney function are the primary correlates of fasting plasma total homocysteine levels in non-diabetic and diabetic adults. Results from the 1999–2002 National Health and Nutrition Examination Survey

Glen E. Duncan, Sierra M. Li, Xiao‐Hua ZhouNutrition 2005 · DOI

TL;DR

This study reveals that while elevated fasting plasma total homocysteine (tHcy) is observed in individuals with impaired glucose tolerance and diabetes, its primary drivers are age and kidney function, not glucose metabolism itself. This finding challenges previous assumptions and suggests a shift in focus for understanding and managing tHcy levels, particularly in the context of cardiovascular risk.

What Problem Does This Paper Address?

Cardiovascular disease (CVD) is a major concern for individuals with diabetes, who face a significantly higher risk compared to non-diabetics. While traditional risk factors like hypertension and dyslipidemia are more prevalent in diabetics, they don't fully explain the excess mortality. Plasma total homocysteine (tHcy) has emerged as a potential independent risk factor for CVD, and it's known to be elevated in individuals with diabetes. However, the precise reasons for this elevation and its relationship with glucose metabolism and diabetes status have remained unclear. Previous studies hinted at a link between tHcy and metabolic control in diabetes, but these were often based on smaller, specific cohorts. This paper aims to clarify the relationship between fasting glucose status, diabetes, and fasting tHcy levels in a large, representative sample of the US adult population, and to identify the key factors influencing these tHcy levels.

Methods

The researchers utilized data from the 1999-2002 National Health and Nutrition Examination Survey (NHANES), a large, stratified, multistage probability sample of the US civilian non-institutionalized population. They analyzed data from adults aged 20 and older who had fasted for at least 8 hours.

Two main groups were analyzed:

  1. Non-diabetic adults: These individuals were categorized into three groups based on their fasting plasma glucose (FPG) levels: normal fasting glucose (NFG, < 100 mg/dL), impaired fasting glucose (IFG, ≥ 100 to < 126 mg/dL), and provisional diagnosis of diabetes (DFG, ≥ 126 mg/dL).
  2. Adults with a self-report history of diabetes: This group was examined separately.

Statistical analyses were performed using SAS survey procedures, accounting for the complex survey design (e.g., using fasting weights and pseudo-primary sampling units) to ensure accurate estimation of means, confidence intervals, and standard errors. Univariate and multivariate linear regression models were employed to identify correlates of fasting tHcy, with adjustments made for various demographic and physiological variables.

Datasets

The study used data from the combined 1999-2000 and 2001-2002 National Health and Nutrition Examination Survey (NHANES). This dataset represents a large, nationally representative sample of the US civilian non-institutionalized population. No new datasets were introduced.

Key Insights and Ideas

  • Age and Kidney Function Reign Supreme: The most striking finding is that age and kidney function (measured by estimated creatinine clearance, CCr) are the dominant factors influencing fasting tHcy levels, both in non-diabetic and diabetic individuals. This suggests that as we age and our kidneys' filtering capacity declines, our tHcy levels tend to rise, irrespective of glucose metabolism.
  • Glucose Metabolism's Weaker Role: Contrary to some previous assumptions, measures of glucose metabolism (fasting glucose and HbA1c) played a much weaker, though still significant, role in predicting tHcy levels. In fact, fasting glucose status was not a significant independent predictor of tHcy in non-diabetic subjects when other factors were accounted for.
  • Diabetes Status Alone Isn't the Whole Story: While individuals with elevated fasting glucose (IFG and DFG) and those with a self-reported history of diabetes did show higher tHcy levels compared to those with normal fasting glucose, these elevations were largely explained by age and kidney function. This implies that the increased CVD risk associated with diabetes might not be solely due to tHcy being directly driven by glucose dysregulation.
  • Potential Impact of Fortification: The authors speculate that US cereal grain fortification programs, which began in 1998, might have attenuated fasting tHcy levels in the US population compared to other countries, potentially explaining some discrepancies with previous international studies.

Key Results

  • Fasting tHcy levels were significantly higher in non-diabetic subjects with DFG (8.6 µmol/L) and IFG (8.3 µmol/L) compared to those with NFG (7.4 µmol/L).
  • Diabetic subjects had tHcy levels (8.3 µmol/L) similar to non-diabetic subjects with DFG and IFG.
  • Age (r = 0.38 to 0.44) and estimated creatinine clearance (CCr, r = -0.35 to -0.46) were strong correlates of fasting tHcy in both non-diabetic and diabetic subjects (P < 0.001).
  • Fasting glucose and HbA1c were weaker, but still significant, correlates of tHcy.
  • In multivariate regression models, age and kidney function (CCr or serum creatinine) were the primary predictors of fasting tHcy. HbA1c was not a significant independent predictor in either non-diabetic or diabetic subjects.

Limitations and Future Work

  • Cross-sectional Design: The study's cross-sectional nature prevents the determination of causality. It can show associations but not definitively prove that age and kidney function cause the tHcy elevation.
  • Self-Reported Diabetes: The reliance on self-reported diabetes history for one group introduces potential inaccuracies.
  • Sex Differences: While explored, the differential impact of sex on tHcy correlates warrants further investigation.
  • Genotype Data: The absence of MTHFR genotype data, a known factor in homocysteine metabolism, limits a complete understanding.
  • Clinical Significance of Small Differences: The observed differences in tHcy levels, while statistically significant, were relatively small and within the generally accepted normal range (< 15 µmol/L). The clinical significance of these differences, particularly concerning CVD risk, remains to be fully elucidated.

Future research could benefit from longitudinal studies to establish causality, incorporate genetic data, and explore the clinical implications of these findings in more detail, especially regarding interventions targeting age and kidney function for managing tHcy levels.

Summary updated

Abstract

Fasting tHcy levels are elevated among non-diabetic adults with elevated fasting glucose levels, compared to persons with normal fasting glucose levels, and among diabetic adults. However, elevations in fasting tHcy appear to be mediated primarily by age and kidney function, and not by measures of glucose metabolism.
BibTeX
@inproceedings{duncan2005age,
  author = {Glen E. Duncan and Sierra M. Li and Xiao‐Hua Zhou},
  title = {{Age and kidney function are the primary correlates of fasting plasma total homocysteine levels in non-diabetic and diabetic adults. Results from the 1999–2002 National Health and Nutrition Examination Survey}},
  booktitle = {Nutrition},
  year = {2005},
  doi = {10.1186/1743-7075-2-13},
}
Figure